PODCAST: Williams Mullen's Trending Now: An IP Podcast - Who Owns AI Innovation? IP in the Age of Artificial Intelligence
Innovating with AI: Ensuring You Own Your Inventions
Using Innovative Technology to Advance Trial Strategies | Episode 70
John Harmon on the Evolving Impact of Artificial Intelligence on Intellectual Property
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions (Podcast)
From an Artistic Eye to AI, Building Bristles into a Buzzworthy Company with Tina Tang
Cases Updated in CNIPA Guidelines - Eligibility & Inventiveness for AI & Business Method Applications
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Five Popular Misconceptions about Patents
Episode #11 - Successful Serial Entrepreneurship with Seth Burgett
Nonpublication Requests For Patent Applications Part 3: Pitfalls
What Is a Patent and How Do I Get One
Nonpublication Requests For Patent Applications Part 1: Benefits
[IP Hot Topics Podcast] Innovation Conversations: Dr. Claire Fraser
Monthly Minute | Commercialization of an Invention
JONES DAY PRESENTS®: Artificial Intelligence: The Growing Role of AI on Patents
Hedy Lamarr - When Beauty and Brains Collide (Women's History Month)
Pepper Hamilton Higher Education "In Brief" Webinar Series: Intellectual Property Basics - What Every Higher Education Administrator Needs To Know
Podcast: Artificial Intelligence and Intellectual Property Considerations
Protecting IP Through Employment Law
The Federal Circuit’s recent decision in Global Health Solutions LLC v. Selner is its first review of a rare patent dispute resolution process under the America Invents Act (AIA). The decision serves as a warning that proving...more
A podcast from JAMS featuring Steven Bauer and Sarah Geers on how ADR can play a pivotal role in resolving IP-related disputes in the life sciences industry - In this podcast, Steven Bauer, mediator and arbitrator at...more
As we continue our battle against COVID-19, one of the successes is the speed with which pharmaceutical companies have developed vaccines. For those not familiar with the science and the process of getting new drugs to...more